About Chronos Therapeutics

What We Do

Chronos is an Oxford-based biotechnology company operating a semi-virtual R&D model to develop a portfolio of therapies in degenerative and behavioral brain diseases. The team utilises a network of industry-leading contract research organisations to develop NCE’s and repurpose existing launched drugs. Chronos also has a dedicated laboratory in Oxford which screens for activity of drugs in brain disease through its proprietary platform, Chronoscreen™

Our Focus

Degenerative and Behavioural Diseases of the Brain and Nervous System via:

Acquisition, discovery and development of novel proprietary lead candidates.
Repositioning FDA/EMA approved drugs.

LEARN MORE

Targets

Specific areas we target:

ALS (Lou Gehrig’s Disease)
Other Neurological Diseases
Fatigue
Addictive Behaviour

LEARN MORE

THE TEAM

The team has decades of broad ranging expertise in research, drug discovery, drug development, regulatory approval, pricing, commercialisation and financing.

BOARD OF DIRECTORS

  • Dr. Michael Moore PhD, DSc, FRCpath Chairman
  • Dr. Huw Jones PhD Chief Executive Officer
  • Christian Hoyer Millar MA, Hons (Oxon) Director
  • Martin Diggle MA (Oxon) Non-Executive Director
  • Dr. Chris Towler PhD Non-Executive Director
  • Theodora Harold MA (Cantab) Non-Executive Director

MANAGEMENT TEAM

  • Dr. Huw Jones PhD Chief Executive Officer
  • Dr. Fraser Murray PhD MBA Chief Scientific Officer
  • Dr. David Eckland PhD, FRCP Chief Medical Officer
  • Dr. Helen Kuhlman PhD VP Corporate Development
  • Dr. Timothy Schulz-Utermoehl PhD VP Pre-Clinical Development
  • Tanya Palmer Clinical Development Director
  • Mark Donaldson BA, FCCA Finance Director
  • Dr. Kevin Thompson DPhil Director, Chronoscreen™
  • Martin Reeves Strategic Advisor

ADVISORY BOARD

  • Professor Chris Shaw MBChB, MD, FRACP, FRCP (Hon), FMedSci, FANA Kings College London. Professor of Neurology and Neurogenetics at the Institute of Psychiatry, Psychology and Neuroscience
  • Professor Merit Cudkowicz M.D. MSc. Harvard Medical School; Director, Mass. Gen. ALS Clinic. ALS Clinical Consultant
  • Professor Ammar Al-Chalabi MB ChB, PhD, FRCP Kings College Hospital; Director King's MND Care and Research Centre, and King's Motor Nerve Clinic
  • Professor Kevin Talbot MB BS, DPhil, FRCP University of Oxford; Head of Clinical Neurology and Professor of Motor Neuron Biology
  • Professor Albert Ludolph Professor of Neurology and Chairman of the Department of Neurology at the University Hospital and Medical Faculty of Ulm

CAREERS

Chronos Therapeutics is addressing the many unmet medical needs through screening, discovery, repositioning and acquisition.

At Chronos Therapeutics we work hard to develop much-needed medication for degenerative and behavioural diseases of the brain and nervous system.

The Chronos team combines the highest quality scientific knowledge with corporate insights to create a fast-paced environment supporting the Company strategy.

Chronos Therapeutics is always interested to acquire additional knowledge and support within its different teams. If you think you have what it takes to work with us and add to the corporate culture of rapid discovery, diversity, and creativity, we are keen to hear from you.

Email us at info@chronostherapeutics.com.

BUSINESS DEVELOPMENT

We are constantly evaluating new opportunities for in-licensing and are also open to collaborations on our existing portfolio. If you would like to discuss collaboration please send an e-mail to businessdevelopment@chronostherapeutics.com

Contact Us

Want to get in touch? Send us an email.

Not readable? Change text. captcha txt